MTERF9 Antibody

What is mTERF9 and what is its molecular function in plant chloroplasts?

mTERF9 belongs to the mitochondrial transcription termination factor family, which are nuclear-encoded nucleic acid binders defined by degenerate tandem helical-repeats of approximately 30 amino acids. In Arabidopsis, mTERF9 is localized to chloroplasts where it promotes the accumulation of 16S and 23S rRNAs . The protein integrates both protein-protein and protein-RNA interactions to facilitate chloroplast ribosomal assembly and translation. Unlike what its name might suggest, mTERF9's primary function is not transcription termination but rather promoting proper ribosome biogenesis in chloroplasts .

How does mTERF9 associate with chloroplast ribosomes?

mTERF9 primarily associates with the small 30S ribosomal subunit in chloroplasts, as demonstrated by sucrose gradient sedimentation analyses. Immunoblot analysis shows that mTERF9 comigrates with RPS1 (a protein component of the 30S subunit), indicating its association with this ribosomal particle . Furthermore, mTERF9 is also detected in both light and heavy polysomes as well as in fractions containing free ribosomes, suggesting its continued association with ribosomes during active translation . This association is sensitive to puromycin treatment, which causes mTERF9 to be released from heavy complexes to lighter ones containing mostly monosome particles .

What experimental evidence demonstrates mTERF9's interaction with RNA?

Multiple complementary approaches have established mTERF9's RNA-binding capacity. RNA co-immunoprecipitation (RIP) assays followed by microarray analysis (RIP-chip) revealed a prominently enriched peak (>20-fold) corresponding to 16S rRNA in mTERF9 immunoprecipitates . Quantitative RT-PCR analysis of immunoprecipitated RNAs showed that mTERF9 bound approximately 10% of input 16S rRNAs but less than 2% of 23S rRNA . Slot-blot hybridization further confirmed strong enrichment of 16S rRNA and weaker enrichment of 23S and 5S rRNAs in mTERF9 immunoprecipitates . These multiple lines of evidence consistently demonstrate mTERF9's predominant interaction with 16S rRNA in vivo.

What phenotypes are associated with mterf9 mutants?

The loss of mTERF9 in null mterf9 mutants compromises the assembly of chloroplast ribosome subunits, with a particularly severe effect on the 30S subunit . Sucrose gradient sedimentation analysis reveals that in mterf9 mutants, both RPL33 (a 50S subunit component) and RPS1 (a 30S subunit component) sedimentation patterns shift to lower molecular-weight fractions, with RPS1 showing a more pronounced shift . This indicates defective assembly of ribosomal subunits, especially the 30S subunit. Additionally, mterf9 mutants show reduced accumulation of chloroplast rRNAs, particularly 16S and 23S rRNAs .

How does mTERF9 contribute to chloroplast ribosomal assembly at the molecular level?

mTERF9 facilitates ribosomal assembly through multiple mechanisms involving both RNA and protein interactions. It primarily binds to 16S rRNA, which is a component of the 30S ribosomal subunit . This binding likely stabilizes the rRNA and promotes proper folding for assembly with ribosomal proteins. Protein interaction studies revealed that mTERF9 directly interacts with ERA1, an Arabidopsis ortholog of the bacterial YqeH/ERA assembly factor for the 30S ribosomal subunit . It also interacts with PSRP2 and RPL1, proteins of the 30S and 50S ribosomal subunits, respectively . The comprehensive analysis of mTERF9's in vivo protein interactome identified many subunits of the 70S ribosome whose assembly is compromised in the null mterf9 mutant . These interactions collectively promote the stable assembly of functional chloroplast ribosomes.

What specific protein interactions does mTERF9 establish, and how are they affected by RNase treatment?

Co-immunoprecipitation experiments with and without RNase treatment identified 158 and 173 proteins, respectively, that significantly interact with mTERF9 . These proteins fall into seven functional categories: ribosomal proteins of the small and large subunits, CPN60 chaperonins, rRNA processing/translation factors, RNA binding proteins, components of the transcriptional active chromosome, and others .

RNase treatment differentially affected these interactions:

• Reduced: Chloroplast ribosomal proteins (particularly of the large subunit), rRNA processing/translation factors, and TAC components

• Increased: RNA binding proteins and proteins from the "others" category

• Unchanged: All 6 subunits (CPN60α1-2, CPN60β1-4) of the chloroplast CPN60 chaperonin complex remained among the most enriched proteins in both conditions

In total, 92 proteins were commonly found in both the untreated and RNase-treated co-immunoprecipitates, suggesting they interact with mTERF9 independently of RNA .

What is the functional significance of mTERF9's interaction with CPN60 chaperonins?

The interaction between mTERF9 and CPN60 chaperonins is particularly strong and RNA-independent, as all six subunits (CPN60α1-2, CPN60β1-4) of the chloroplast CPN60 chaperonin complex were consistently among the most enriched proteins in mTERF9 co-immunoprecipitates regardless of RNase treatment . Direct physical interaction between mTERF9 and CPN60β1 and β3 subunits was confirmed through yeast two-hybrid assays .

CPN60 chaperonins are essential for protein folding in chloroplasts, and their interaction with mTERF9 suggests several possible functions:

• They may assist in the proper folding of mTERF9 itself

• They might cooperate with mTERF9 in facilitating the folding and assembly of ribosomal proteins

• The interaction could represent a regulatory mechanism for controlling mTERF9 activity

This interaction highlights a previously unrecognized connection between protein quality control (via chaperonins) and ribosome assembly in chloroplasts.

What techniques are most effective for studying mTERF9-RNA interactions in vivo?

Multiple complementary techniques have proven effective for studying mTERF9-RNA interactions in vivo:

• RNA co-immunoprecipitation (RIP) followed by microarray analysis (RIP-chip): This approach provided a genome-wide view of mTERF9's RNA binding profile, revealing its predominant interaction with 16S rRNA . Stromal extracts from complemented and wild-type plants were subjected to immunoprecipitation with anti-Myc antibodies, and co-immunoprecipitated RNAs were identified by hybridization to tiling microarrays of the Arabidopsis chloroplast genome .

• RIP followed by quantitative RT-PCR: This technique allowed precise quantification of mTERF9's binding to specific rRNAs, showing that it bound 10% of input 16S rRNAs but less than 2% of 23S rRNA .

• Slot-blot hybridization of immunoprecipitated RNAs: This method provided visual confirmation of RNA enrichment in mTERF9 immunoprecipitates and helped validate true targets versus false positives identified in RIP-chip experiments .

These approaches should be performed with appropriate controls, including immunoprecipitation from wild-type plants lacking the epitope tag, to distinguish specific from non-specific interactions.

How can polysome analysis be optimized to study mTERF9's role in translation?

Polysome analysis through sucrose gradient sedimentation has been successfully used to study mTERF9's association with actively translating ribosomes . Key methodological considerations include:

• Gradient preparation: Use a 15-55% sucrose gradient to achieve optimal separation of free ribosomes, monosomes, and polysomes .

• Identification of polysome-containing fractions: Use both immunodetection with antibodies against ribosomal proteins (e.g., RPL2) and visualization of cytosolic rRNAs by RNA electrophoresis on denaturing agarose gels .

• Puromycin control: Treatment with puromycin prior to fractionation serves as an important control to confirm the association with polysomes, as it dissociates ribosomes from mRNA and releases proteins associated with active translation .

• Fraction analysis: Analyze each fraction by immunoblotting with antibodies against mTERF9 (or its epitope tag) and marker proteins for the 30S and 50S ribosomal subunits .

This approach provides insights into whether mTERF9 remains associated with ribosomes during active translation or primarily functions during ribosome assembly.

What controls should be included when performing co-immunoprecipitation experiments with mTERF9 antibodies?

For robust co-immunoprecipitation experiments with mTERF9 antibodies, several important controls should be included:

• Input control: Analyze a portion of the starting material to confirm the presence of proteins of interest before immunoprecipitation .

• Wild-type control: Include immunoprecipitation from wild-type plants lacking the epitope tag to identify non-specific binding to the antibody or beads .

• RNase treatment: Perform parallel immunoprecipitations with and without RNase treatment to distinguish between RNA-dependent and RNA-independent interactions .

• Biological replicates: Conduct experiments in biological triplicates to ensure reproducibility and enable statistical analysis .

• Technical validation: Confirm selected interactions through independent methods such as yeast two-hybrid assays .

• Efficiency control: Verify similar immunoprecipitation efficiency between different conditions (e.g., with and without RNase treatment) to allow direct comparison of results .

These controls help establish the specificity and reliability of identified protein-protein interactions involving mTERF9.

What yeast two-hybrid approaches are most suitable for confirming direct mTERF9 protein interactions?

The standard yeast two-hybrid system may not be optimal for studying mTERF9 interactions because mTERF9 and many ribosomal proteins partially associate with membranes . Instead, a modified yeast two-hybrid assay based on split-ubiquitin, called "DUAL hunter," has proven effective .

Key considerations for this approach include:

• System selection: The DUAL hunter system offers flexibility to select both membrane and cytosolic protein interactions, making it appropriate for mTERF9 studies .

• Candidate selection: Choose candidates from co-immunoprecipitation experiments that were either uniquely identified in RNase-treated samples, found in both RNase-treated and untreated samples, or exclusively found in untreated samples to represent different interaction categories .

• Controls: Include appropriate positive and negative controls to validate the system's specificity and sensitivity.

• Verification: Confirm that the fusion proteins are properly expressed and localized in yeast cells.

Using this approach, direct physical interactions between mTERF9 and five proteins were confirmed: ERA1, PSRP2, RPL1, CPN60β1, and CPN60β3 .

How should researchers interpret data showing mTERF9's association with the transcriptional active chromosome (TAC)?

Ten TAC components were found to co-immunoprecipitate with mTERF9 under both RNase-treated and untreated conditions . This finding requires careful interpretation:

• Functional significance: The co-localization of mTERF9 with TAC components in nucleoids is consistent with nucleoids being a major site for rRNA processing and ribosome assembly in chloroplasts .

• Spatial versus functional association: Researchers should determine whether mTERF9's association with TAC represents a direct functional interaction or simply co-localization within the same sub-organellar compartment. Additional experiments such as in situ localization studies or functional assays may be needed.

• Coordination of transcription and translation: The association might represent a mechanism for coordinating transcription with ribosome assembly and translation in chloroplasts.

• Data presentation: When reporting such associations, researchers should present a table of the specific TAC components identified and their enrichment values to allow for nuanced interpretation.

What experimental approaches can distinguish between mTERF9's roles in ribosome assembly versus translation?

To determine whether mTERF9 functions primarily in ribosome assembly or also plays a direct role in translation, researchers should consider:

• Temporal analysis: Pulse-chase experiments with radiolabeled amino acids can assess whether translation defects in mterf9 mutants are direct or secondary to ribosome assembly defects.

• Ribosome profiling: This technique can provide a genome-wide view of ribosome occupancy on mRNAs and identify specific translation defects in mterf9 mutants.

• In vitro translation assays: Comparing translation efficiency using chloroplast extracts from wild-type and mterf9 mutants can reveal direct effects on translation.

• Polysome structure analysis: Detailed examination of polysome profiles can distinguish between defects in initiation, elongation, or termination phases of translation.

• Conditional mutants: Creating conditional mterf9 mutants might allow researchers to separate early effects (likely related to ribosome assembly) from late effects (potentially related to translation).

Current evidence indicates that mTERF9 primarily associates with the 30S ribosomal subunit but is also found in polysomes, suggesting it may have roles in both processes .

How can quantitative data on mTERF9-rRNA interactions be effectively presented and analyzed?

For clear and informative presentation of quantitative data on mTERF9-rRNA interactions:

This table format allows for easy comparison across different analytical methods and highlights the predominant interaction with 16S rRNA . Researchers should include statistical analyses (e.g., p-values) for quantitative measurements and clearly indicate which interactions were validated by multiple methods.

What are promising research directions for further understanding mTERF9 function?

Based on current knowledge, several promising research directions emerge:

• Structural studies: Determining the three-dimensional structure of mTERF9, particularly in complex with 16S rRNA and/or interacting proteins, would provide mechanistic insights into its function.

• Evolutionary analysis: Comparing mTERF9 function across different plant species could reveal conservation or diversification of its role in chloroplast ribosome assembly.

• Stress responses: Investigating how mTERF9 function is affected by environmental stresses could connect its molecular role to plant physiology and adaptation.

• Interplay with other ribosome assembly factors: Studying genetic and physical interactions between mTERF9 and other known chloroplast ribosome assembly factors would help construct a comprehensive model of ribosome biogenesis.

• Post-translational modifications: Examining whether mTERF9 undergoes post-translational modifications that regulate its activity could reveal regulatory mechanisms of chloroplast ribosome assembly.

These directions would extend our understanding beyond mTERF9's established role in promoting chloroplast ribosomal assembly and translation through protein-protein and protein-RNA interactions .

What technical challenges should researchers anticipate when working with mTERF9 antibodies?

Researchers working with mTERF9 antibodies should anticipate several technical challenges:

• Specificity: Ensuring antibody specificity is crucial, particularly given the presence of multiple mTERF family members (~30) in higher plants . Always validate antibodies using mterf9 null mutants as negative controls.

• Cross-reactivity: Test for potential cross-reactivity with other mTERF family proteins, especially those with high sequence similarity to mTERF9.

• Background in immunoprecipitation: Optimize washing conditions to minimize non-specific binding while maintaining true interactions.

• Epitope accessibility: mTERF9's association with large ribonucleoprotein complexes may mask epitopes. Consider using different antibodies targeting distinct regions of mTERF9.

• Quantification challenges: When quantifying immunoblots, account for the distribution of mTERF9 across multiple complexes of different sizes.

Addressing these challenges requires thorough control experiments and optimization of immunological techniques for each specific application.